Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, the combination of low-level laser therapy and topical minoxidil was found to improve hair density and diameter more effectively than minoxidil alone in treating androgenic alopecia, with similar safety profiles observed in both groups.

This study concludes that in men, telogen effluvium (TE) precedes androgenetic alopecia (AGA), with anagen shortening occurring before follicle miniaturization.

In this study, microneedling radiofrequency followed by topical exosome application was associated with significant increases in hair density and diameter, showing promising potential as a therapy for pattern hair loss.

This study found that platelet-rich plasma significantly improved hair density and thickness compared to monofilament thread implantation in treating androgenetic alopecia.

This study examined the clinical patterns and trichoscopic features of female pattern hair loss at a rural tertiary care hospital, but it does not report any specific results.

The combination of finasteride and minoxidil is as safe and effective as minoxidil alone for improving hair growth in men.

This study found that QR678 Neo® significantly enhanced hair regrowth, density, and shaft diameter in males with advanced androgenetic alopecia undergoing hair transplant surgery, compared to a conventional method, making it a promising adjunct treatment option.

In this study, researchers reported that dermatoscopy effectively differentiates between various types of alopecia and scalp disorders, offering a fast, minimally invasive diagnostic method that improves the standard of care and reduces the necessity for scalp biopsies.

This study explored whether using topical minoxidil can temporarily increase hair shedding, but results are not reported.

Polynucleotides effectively promote hair regrowth in androgenetic alopecia without serious side effects.

This study observed that indigenous South Africans with natural afro-textured hair have lower hair densities, varying shaft diameters, and distinct follicular unit patterns compared to other racial groups, with significant gender differences in some parameters, highlighting the need for tailored reference values in clinical settings.

In this study, oral minoxidil treatment significantly increased serum VEGF levels and improved hair growth measures compared to a control group, suggesting its potential as an effective approach for promoting hair regrowth in androgenetic alopecia.

This pilot study found that using skin patting and iontophoresis to deliver a 6% dutasteride gel led to significant improvements in hair density and shaft diameter in men and postmenopausal women with treatment-resistant androgenetic alopecia, with no reported adverse events.

This study found distinct sex-based differences in the microscopic characteristics of scalp hair among a Nigerian population, providing valuable forensic data specific to this group.

This study found that topical minoxidil 5% was more effective than cetirizine 1% in improving hair parameters in male androgenetic alopecia, though cetirizine showed promising safety and some efficacy.

This study observed that after 12 weeks of using the nutraceutical Alpenta, women with acute or chronic telogen effluvium experienced significant improvements in hair growth parameters, including increased anagen hair percentage, hair density, and diameter, with high patient satisfaction and good product tolerability reported.

This review discusses the role of trichoscopy in diagnosing and managing various alopecia types, highlighting its ability to detect specific patterns in both scarring and non-scarring forms, thus aiding in treatment decisions and reducing biopsy necessity.

In this study, a topical hair growth serum containing ingredients like procapil and redensyl was found to be safe and effective for subjects with androgenic alopecia, significantly improving hair density, thickness, and Anagen:Telogen ratio after 120 days, with no observed adverse effects.

MpowerTM may improve hair growth and satisfaction more than plain minoxidil, with mild side effects.

In this phase I/II clinical trial, placenta-derived mesenchymal stem cell exosome therapy significantly improved hair density and diameter, and reduced hair loss in patients with androgenetic alopecia, though further large-scale studies are needed to confirm these results and investigate the underlying molecular mechanisms.

Certain combination therapies, like microneedling with minoxidil, are more effective for female-pattern hair loss than other treatments.

This study concluded that trichoscopy is an effective, non-invasive tool for diagnosing telogen effluvium, with significant differences in trichoscopic findings between frontal and occipital scalp regions, aiding in distinguishing it from androgenetic alopecia for early diagnosis.

In this meta-analysis, researchers found that oral and topical minoxidil treatments for androgenetic alopecia had similar efficacy in improving hair density and diameter, but oral minoxidil resulted in a higher incidence of hypertrichosis compared to topical use.

In this retrospective analysis, dutasteride mesotherapy was used in 10 patients with androgenetic alopecia and resulted in hair density and width changes measured at the scalp, but specific efficacy results are not detailed in the abstract.

In this study, participants with androgenetic alopecia who used an LED helmet emitting red and green light experienced significant improvements in hair growth measures, with red light showing superior results in increasing hair diameter and reducing vellus hair density over 6 months.

This study found that combining Chuzhi Shengfa Tablets with either ketoconazole shampoo or 5% minoxidil foam significantly improved hair density, hair diameter, and reduced scalp oil in men with androgenetic alopecia, without increasing adverse reactions.

This study found that both red and green LED therapies combined with a microneedling patch significantly improved hair density and diameter in androgenetic alopecia patients over 24 weeks, with no serious side effects and similar efficacy between the two light wavelengths.

This study found that oral administration of solubilized sturgeon oil in mice promoted hair growth and positively influenced the gut microbiome associated with hair growth promotion.

This study aimed to assess pruritus in lichen planopilaris and frontal fibrosing alopecia, analyzing its correlation with dermoscopic features, but it reports no specific clinical results.

This study explores the potential of rosemary oil for stimulating hair growth, focusing on developing ROS-loaded microsponges to enhance its permeability for topical application, but results are not reported.